Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients
- PMID: 17899433
- DOI: 10.1007/s11255-007-9274-y
Renal cell carcinoma under 35 years of age: comparison of survival rates for symptomatic and asymptomatic patients
Abstract
Introduction: Recent studies suggest that RCC detected in young adults is likely to be more symptomatic and potentially aggressive, since young patients are less likely to undergo radiologic examinations unless they have symptoms. The aim of this study is to identify the clinical, biological and histological entities of RCC in young patients, and to compare survival rates for symptomatic and asymptomatic patients.
Patients and methods: A review of 2,510 records of patients with RCC from 1965 to 2007 was conducted. Thirty-four patients under 35 years old were identified. The Kaplan-Meier system was used to calculate the cumulative survival rate at five and ten years post-surgery as well as the survival prognoses for patients who presented with symptoms and for patients for whom RCC was incidentally diagnosed.
Results: The differences in cumulative survival rates at five and ten years between patients who presented with symptoms and patients whom RCC was incidentally diagnosed were not significant (P = 0.06). The Kaplan-Meier system used to calculate the cumulative survival rate at five and ten years postsurgery yielded survival rates of 79.4% at five years and 73.5% at ten years, respectively.
Discussion: The biological and histological entities as well as the survival prognosis for RCC in young patients are similar to those for patients who present with RCC in the sixth and seventh decades of life. Additionally, young adults are likely to be more symptomatic, but the difference in survival between patients with symptoms and those without symptoms is not statistically significant.
Similar articles
-
Impact of Young Age at Diagnosis on Survival in Patients with Surgically Treated Renal Cell Carcinoma: a Multicenter Study.J Korean Med Sci. 2016 Dec;31(12):1976-1982. doi: 10.3346/jkms.2016.31.12.1976. J Korean Med Sci. 2016. PMID: 27822938 Free PMC article.
-
Gender-specific clinicopathological features and survival in patients with renal cell carcinoma (RCC).BJU Int. 2012 Jul;110(2 Pt 2):E28-33. doi: 10.1111/j.1464-410X.2011.10667.x. Epub 2011 Nov 15. BJU Int. 2012. PMID: 22085161
-
Influence of tumour-associated symptoms on the prognosis of patients with renal cell carcinoma.Scand J Urol Nephrol. 2008;42(5):406-11. doi: 10.1080/00365590802022151. Scand J Urol Nephrol. 2008. PMID: 18932106
-
Renal cell carcinoma in young adults: incidence, disease outcome and review of the literature.Arch Esp Urol. 2002 Oct;55(8):969-75. Arch Esp Urol. 2002. PMID: 12455292 Review.
-
Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death.World J Urol. 2014 Jun;32(3):607-13. doi: 10.1007/s00345-014-1285-6. Epub 2014 Apr 8. World J Urol. 2014. PMID: 24710683 Review.
Cited by
-
Clinical symptoms related to renal cell carcinoma are independent prognostic factors for intraoperative complications and overall survival.Int Urol Nephrol. 2009 Dec;41(4):835-42. doi: 10.1007/s11255-009-9539-8. Epub 2009 Mar 13. Int Urol Nephrol. 2009. PMID: 19283507
-
Characteristics of renal cell carcinoma in Saudi patients below the age of 50 years.Urol Ann. 2022 Jan-Mar;14(1):15-20. doi: 10.4103/ua.ua_14_21. Epub 2021 Dec 28. Urol Ann. 2022. PMID: 35197697 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical